The ForeseeHome™ AMD Monitor is the first ophthalmic device linking patients and doctors between eye exams for ongoing monitoring of wet age-related macular degeneration (AMD). This telemedicine based system gives doctors access to valuable patient data through a secure online connection, allowing frequent and personalized monitoring of patients at risk of vision loss from the devastating effects of wet AMD.
The ForeseeHome™ AMD Monitor is indicated for use as follows:
The Foresee Home is intended for use in the detection and characterization of central and paracentral metamorphopsia (visual distortion) in patients with age-related macular degeneration, as an aid in monitoring progression of disease factors causing metamorphopsia including but not limited to choroidal neovascularization (CNV). It is intended to be used at home for patients with stable fixation.
The Foresee Home™ is not intended to diagnose; diagnosis is the responsibility of the prescribing eye-care professional.
The appropriate type of patients are intermediate AMD as defined by the Age related Eye Disease Study (AREDS), National Eye Institute.1
1. Age-Related Eye Disease Study Research Group. A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta caroteen, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8. Arch Ophthalmol 2001; 119: 1417-1436.
ForeseeHome™ Device
ForeseeHome™ Test
ForeseeHome™ Analysis
ForeseeHome™ Telemedicine